Scholarlink

Background <p>Atherosclerotic cardiovascular disease (ASCVD) is&#xa0;cardiovascular disease caused by atherosclerosis. Serum carcinoembryonic antigen (CEA), a common tumor marker, is positively associated with arterial stiffness in healthy adults. Therefore, the aim of this study was to explore the potential association between serum CEA levels and ASCVD in patients with type 2 diabetes mellitus (T2DM).</p> Methods <p>We retrospectively included 1392 patients with T2DM stratified into those with ASCVD and those without ASCVD, and the accumulated data were systematically analyzed between groups.</p> Results <p>A significant&#xa0;increase in&#xa0;serum CEA levels was observed in T2DM patients with ASCVD compared with&#xa0;those without ASCVD (2.70[1.93–3.98] vs. 2.35[1.60–3.54] ng/mL, p &lt; 0.001). Serum CEA levels were significantly positively correlated with brachial-ankle pulse wave velocity in patients with T2DM (r = 0.151, p &lt; 0.001). Multivariable logistic regression analysis revealed that increased serum CEA levels were independently associated with ASCVD in patients with T2DM (OR = 1.100, 95%CI 1.006–1.203, p = 0.037).</p> Conclusion <p>Increased serum CEA levels were&#xa0;independently associated with ASCVD in patients with T2DM. The finding highlights&#xa0;that ASCVD may influence the interpretation of serum CEA levels during tumor screening in this population.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Association between serum carcinoembryonic antigen levels and atherosclerotic cardiovascular disease in patients with type 2 diabetes mellitus

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月8日

查看全文
  • You-Fan Peng,
  • Xiang-Hui Su,
  • Ying-Qi Lv,
  • Lin Hu,
  • Teng-Fang Lai,
  • Li Wang,
  • Guo-Feng Wang,
  • Ling Li

摘要

Background

Atherosclerotic cardiovascular disease (ASCVD) is cardiovascular disease caused by atherosclerosis. Serum carcinoembryonic antigen (CEA), a common tumor marker, is positively associated with arterial stiffness in healthy adults. Therefore, the aim of this study was to explore the potential association between serum CEA levels and ASCVD in patients with type 2 diabetes mellitus (T2DM).

Methods

We retrospectively included 1392 patients with T2DM stratified into those with ASCVD and those without ASCVD, and the accumulated data were systematically analyzed between groups.

Results

A significant increase in serum CEA levels was observed in T2DM patients with ASCVD compared with those without ASCVD (2.70[1.93–3.98] vs. 2.35[1.60–3.54] ng/mL, p < 0.001). Serum CEA levels were significantly positively correlated with brachial-ankle pulse wave velocity in patients with T2DM (r = 0.151, p < 0.001). Multivariable logistic regression analysis revealed that increased serum CEA levels were independently associated with ASCVD in patients with T2DM (OR = 1.100, 95%CI 1.006–1.203, p = 0.037).

Conclusion

Increased serum CEA levels were independently associated with ASCVD in patients with T2DM. The finding highlights that ASCVD may influence the interpretation of serum CEA levels during tumor screening in this population.